Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic ...

Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of ...

In 2001, a consultant told a technical committee of the nonprofit National Fire Protection Association (NFPA) that the ...

Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...

Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated ...

The EUV lithography market is expected to reach USD 22.69 billion by 2029 from USD 12.18 billion in 2024, at a CAGR of 13.2% ...

A private startup from Salt Lake City aiming to develop oral antibodies says it has succeeded in an early trial, a ...

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Electronic cigarettes, also known as vapes, entered the U.S. marketplace around 2007. The use of e-cigarettes surged by 900% ...

Sweeping tariffs under consideration by Donald Trump could cause "massive" increases to the cost of producing everyday goods ...

Find out how smoking both traditional cigarettes and e-cigarettes affects lung cancer risk. Get tips to help you quit using all forms of tobacco. Get emotional and practical advice on coping when your ...

6 Dec 24 Hosiery sector revenue set for 10-12% growth in FY24: CRISIL... CRISIL Ratings forecasts 10-12% revenue growth for Indian hosiery manufacturers this fiscal year, driven by rural demand ...